INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $14,000 | 0.0% | 5,294 | -36.8% | 0.00% | – |
Q2 2022 | $14,000 | -53.3% | 8,371 | 0.0% | 0.00% | – |
Q1 2022 | $30,000 | -28.6% | 8,371 | 0.0% | 0.00% | – |
Q4 2021 | $42,000 | -30.0% | 8,371 | 0.0% | 0.00% | – |
Q3 2021 | $60,000 | -23.1% | 8,371 | 0.0% | 0.00% | – |
Q2 2021 | $78,000 | 0.0% | 8,371 | 0.0% | 0.00% | – |
Q1 2021 | $78,000 | +44.4% | 8,371 | +37.9% | 0.00% | – |
Q4 2020 | $54,000 | -22.9% | 6,072 | 0.0% | 0.00% | – |
Q3 2020 | $70,000 | -57.3% | 6,072 | 0.0% | 0.00% | – |
Q2 2020 | $164,000 | – | 6,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
Keystone Financial Group | 109,897 | $42,751 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |